Jazz Pharmaceuticals plc (JAZZ) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Jazz Pharmaceuticals shareholders at a glance

The largest holder of Jazz Pharmaceuticals stock is BlackRock Advisors LLC, with 5.5 million shares (8.52% of the company), worth about $1.39 billion as of September 25, 2026. The 10 largest holders together own 43.8%.

In Q2 2026, 673 institutional holdings reports listed shares worth $15.60 billion.

Insiders reported 85 transactions in the last two years: 35 sales worth $45.68 million and 1 purchase. The newest one on file is from May 1, 2026 (Cozadd Bruce C, Director).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 1, 2026.

JAZZ logo

Jazz Pharmaceuticals plc

JAZZIreland
Healthcare

Shareholders Summary

2026Q2

Filings
673
Options Value
$95.80M
Value (excl. Options)
$15.60B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Jazz Pharmaceuticals shareholders

HolderShares% of companyValue
BlackRock Advisors LLC5.5 million8.52%$1.4B
Fidelity Management & Research Co. LLC4.6 million7.10%$1.2B
Vanguard Portfolio Management LLC3.0 million4.68%$761.0M
Vanguard Capital Management LLC2.7 million4.21%$684.0M
Capital Research & Management Co. (World Investors)2.7 million4.16%$676.0M
LSV Asset Management2.3 million3.50%$570.0M
Fiduciary Trust Company International2.0 million3.09%$503.0M
State Street Corporation2.0 million3.08%$501.0M
BNY Mellon Investment Adviser, Inc.1.9 million2.97%$483.0M
DFA Australia Ltd.1.6 million2.54%$413.0M

As of September 25, 2026.

Jazz Pharmaceuticals institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026673–$15.6B
Q1 202660165.0 million$12.3B
Q4 202561063.4 million$10.8B
Q3 202552862.6 million$8.3B
Q2 202552262.2 million$6.6B
Q1 202557760.1 million$7.5B
Q4 202452859.3 million$7.3B
Q3 202449659.6 million$6.6B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Jazz Pharmaceuticals insider trades

InsiderDateTitleTransactionValue
Cozadd Bruce CMay 1, 2026DirectorSale at price 203.33 per share.$1.2M
Cozadd Bruce CApr 1, 2026DirectorSale at price 190.22 - 191.74 per share.$1.1M
Carr PatriciaMar 9, 2026OfficerSale at price 182.94 per share.$235,444
Cozadd Bruce CMar 3, 2026DirectorSale at price 186.09 - 187.84 per share.$1.1M
Carr PatriciaFeb 27, 2026OfficerSale at price 190.91 - 194.11 per share.$456,466
Riedel Norbert GFeb 27, 2026DirectorSale at price 192.00 per share.$655,680
Riedel Norbert GFeb 27, 2026DirectorConversion of Exercise of derivative security at price 138.08 per share.$471,543
Henderson Mary ElizabethFeb 26, 2026OfficerSale at price 194.49 per share.$1.0M
Patil Neena MFeb 26, 2026OfficerSale at price 189.81 - 193.60 per share.$10.7M
Patil Neena MFeb 26, 2026OfficerConversion of Exercise of derivative security at price 113.10 - 137.12 per share.$6.5M
Love Ted WendellFeb 26, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Iannone RobertFeb 26, 2026OfficerStock Award(Grant) at price 0.00 per share.–

Newest 12 of 85 insider transactions in the last two years.

Questions and answers

Who owns the most Jazz Pharmaceuticals stock?

BlackRock Advisors LLC, with 8.52% of the company (as of September 25, 2026). Next: Fidelity Management & Research Co. LLC (7.10%) and Vanguard Portfolio Management LLC (4.68%).

How many institutions own Jazz Pharmaceuticals stock?

673 institutional holdings reports listed Jazz Pharmaceuticals shares in Q2 2026 worth $15.60 billion.

Are Jazz Pharmaceuticals insiders buying or selling the stock?

In the last two years insiders reported 35 sales and 1 purchase (85 transactions in all); the newest on file is from May 1, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube